πŸ‡ΊπŸ‡Έ FDA
Patent

US 7306804

HIV-specific T-cell induction

granted A61KA61K2239/31A61K39/00

Quick answer

US patent 7306804 (HIV-specific T-cell induction) held by The Board of Regents of the University of Texas System expires Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K2239/31, A61K39/00, A61K40/00, A61K40/19